Gritstone bio Inc. (NASDAQ: GRTS) Stock Information | RedChip

Gritstone bio Inc. (NASDAQ: GRTS) Listen to this Section


$0.51
-0.0201 ( -3.79% ) 1.4M

Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.

Market Data


Open


$0.51

Previous close


$0.53

Volume


1.4M

Market cap


$59.07M

Day range


$0.50 - $0.58

52 week range


$0.45 - $3.33

Insider Ownership Transactions

Total Amount Purchased: -685,529.00 | $ -349,619.79

Date Type Amount Purchased Purchaser
2024-06-26 Sale -325000.00 Allen Andrew R
2024-06-20 Sale -51800.00 Fisher Clare
2024-06-20 Sale -51800.00 Agarwal Shefali
2024-06-20 Sale -51800.00 Corey Lawrence
2024-06-20 Sale -7379.00 Webster Stephen W
2024-06-20 Sale -51800.00 Jones Elaine V
2024-06-20 Sale -51800.00 Rizvi Naiyer
2024-05-17 Sale -47873.00 Allen Andrew R
2024-05-17 Sale -27128.00 Economides Vassiliki
2024-05-17 Sale -19149.00 Hawryluk Matthew

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 79 Aug 13, 2024
8-k 8K-related 12 Aug 13, 2024
4 Insider transactions 1 Jun 26, 2024
8-k 8K-related 13 Jun 25, 2024
8-k 8K-related 13 Jun 24, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.